Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials
and review articles, and all other scientific articles relating to the etiopathogenesis, epidemiology, prevention, clinical features,
diagnosis, treatment and management of patients with neoplasms in the head and neck, and orofacial disease in patients with malignant
disease.
Oral Oncology is of interest to head and neck surgeons and oncologists, maxillo-facial surgeons, oto-rhino-laryngologists,
plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general practitioners,
general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians,
occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals
in end of life care, as well as others interested in these fields.
Research or Review papers of high quality and that make a
contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue,
oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base and craniofacial region, and the related hard
and soft tissues and lymph nodes) and craniofacial disease in patients with malignant disease:
• Etiopathogenesis: natural history
of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth
factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention;
screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging
and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging
and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular
markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms
of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics
(new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including
flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. •
Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological
interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction,
deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork. •
Multicentre studies.
